Physician profile
Kellie Higgins
NPI 1609133974
$2,282.43
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $740 · 2020: $85.29 · 2021: $274 · 2022: $205 · 2023: $719 · 2024: $260.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $594 · Travel and Lodging: $385.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $593.68 |
| Travel and Lodging | $384.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $787.90 | 2019-2022 | |
| Arthrex, INC. | $278.08 | 2023 | |
| Crossroads Orthopedics, LLC | $230.91 | 2023 | |
| Medline Industries LP | $180.78 | 2024 | |
| Alafair Biosciences, INC. | $162.57 | 2023-2024 | Versawrap |
| Smith+Nephew, INC. | $136.28 | 2019-2021 | |
| Paragon 28, INC. | $123.60 | 2022 | |
| Sanara Medtech INC. | $118.67 | 2020-2021 | |
| Acera Surgical, INC. | $72.59 | 2021-2022 | |
| Kerecis Limited | $59.64 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Averitas Pharma INC. | $40.27 | 2023 | Qutenza |
| Djo, LLC | $26.19 | 2023 | Donjoy |
| Derma Sciences, INC. | $26.10 | 2019 | |
| Sandoz INC. | $22.94 | 2019 | |
| Grt US Holding, INC. | $15.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kellie Higgins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.